313 related articles for article (PubMed ID: 32739973)
1. Non-hormonal mediators of uterine fibroid growth.
Cetin E; Al-Hendy A; Ciebiera M
Curr Opin Obstet Gynecol; 2020 Oct; 32(5):361-370. PubMed ID: 32739973
[TBL] [Abstract][Full Text] [Related]
2. Preoperative medical therapy before surgery for uterine fibroids.
Lethaby A; Puscasiu L; Vollenhoven B
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD000547. PubMed ID: 29139105
[TBL] [Abstract][Full Text] [Related]
3. Selective progesterone receptor modulators (SPRMs) for uterine fibroids.
Murji A; Whitaker L; Chow TL; Sobel ML
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010770. PubMed ID: 28444736
[TBL] [Abstract][Full Text] [Related]
4. Role of vitamin D in uterine fibroid biology.
Brakta S; Diamond JS; Al-Hendy A; Diamond MP; Halder SK
Fertil Steril; 2015 Sep; 104(3):698-706. PubMed ID: 26079694
[TBL] [Abstract][Full Text] [Related]
5. Hormones and pathogenesis of uterine fibroids.
Reis FM; Bloise E; Ortiga-Carvalho TM
Best Pract Res Clin Obstet Gynaecol; 2016 Jul; 34():13-24. PubMed ID: 26725037
[TBL] [Abstract][Full Text] [Related]
6. Fibroid growth and medical options for treatment.
Chabbert-Buffet N; Esber N; Bouchard P
Fertil Steril; 2014 Sep; 102(3):630-9. PubMed ID: 25171950
[TBL] [Abstract][Full Text] [Related]
7. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
Lethaby A; Vollenhoven B; Sowter M
Cochrane Database Syst Rev; 2001; (2):CD000547. PubMed ID: 11405968
[TBL] [Abstract][Full Text] [Related]
8. Estrogen Receptors and Signaling in Fibroids: Role in Pathobiology and Therapeutic Implications.
Borahay MA; Asoglu MR; Mas A; Adam S; Kilic GS; Al-Hendy A
Reprod Sci; 2017 Sep; 24(9):1235-1244. PubMed ID: 27872195
[TBL] [Abstract][Full Text] [Related]
9. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
Lethaby A; Vollenhoven B; Sowter M
Cochrane Database Syst Rev; 2000; (2):CD000547. PubMed ID: 10796723
[TBL] [Abstract][Full Text] [Related]
10. Medical management of fibroids.
Sankaran S; Manyonda IT
Best Pract Res Clin Obstet Gynaecol; 2008 Aug; 22(4):655-76. PubMed ID: 18468953
[TBL] [Abstract][Full Text] [Related]
11. An evidence-based approach to hormonal therapies for premenopausal women with fibroids.
Lethaby AE; Vollenhoven BJ
Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):307-31. PubMed ID: 17905660
[TBL] [Abstract][Full Text] [Related]
12. Ulipristal acetate for uterine fibroid-related symptoms.
Puchar A; Luton D; Koskas M
Drugs Today (Barc); 2015 Nov; 51(11):661-7. PubMed ID: 26744741
[TBL] [Abstract][Full Text] [Related]
13. Receptor tyrosine kinases and their hormonal regulation in uterine leiomyoma.
Yu L; Moore AB; Dixon D
Semin Reprod Med; 2010 May; 28(3):250-9. PubMed ID: 20414848
[TBL] [Abstract][Full Text] [Related]
14. EMAS position statement: management of uterine fibroids.
Pérez-López FR; Ornat L; Ceausu I; Depypere H; Erel CT; Lambrinoudaki I; Schenck-Gustafsson K; Simoncini T; Tremollieres F; Rees M;
Maturitas; 2014 Sep; 79(1):106-16. PubMed ID: 24975954
[TBL] [Abstract][Full Text] [Related]
15. Current and Emerging Treatment Options for Uterine Fibroids.
Ali M; Ciebiera M; Wlodarczyk M; Alkhrait S; Maajid E; Yang Q; Hsia SM; Al-Hendy A
Drugs; 2023 Dec; 83(18):1649-1675. PubMed ID: 37922098
[TBL] [Abstract][Full Text] [Related]
16. Progestogens or progestogen-releasing intrauterine systems for uterine fibroids.
Sangkomkamhang US; Lumbiganon P; Laopaiboon M; Mol BW
Cochrane Database Syst Rev; 2013 Feb; (2):CD008994. PubMed ID: 23450594
[TBL] [Abstract][Full Text] [Related]
17. Growth factors and pathogenesis.
Islam MS; Greco S; Janjusevic M; Ciavattini A; Giannubilo SR; D'Adderio A; Biagini A; Fiorini R; Castellucci M; Ciarmela P
Best Pract Res Clin Obstet Gynaecol; 2016 Jul; 34():25-36. PubMed ID: 26527305
[TBL] [Abstract][Full Text] [Related]
18. Emerging treatment options for uterine fibroids.
Donnez J; Arriagada P; Donnez O; Dolmans MM
Expert Opin Emerg Drugs; 2018 Mar; 23(1):17-23. PubMed ID: 29486606
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials.
Stewart EA; Diamond MP; Williams ARW; Carr BR; Myers ER; Feldman RA; Elger W; Mattia-Goldberg C; Schwefel BM; Chwalisz K
Hum Reprod; 2019 Apr; 34(4):623-634. PubMed ID: 30865281
[TBL] [Abstract][Full Text] [Related]
20. Endometrial Angiogenesis of Abnormal Uterine Bleeding and Infertility in Patients with Uterine Fibroids-A Systematic Review.
Don EE; Middelkoop MA; Hehenkamp WJK; Mijatovic V; Griffioen AW; Huirne JAF
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
